Eye care delivery company spun off from parent; RNAi lawsuit thrown out;

> U.K. drug delivery specialist Q Chop spun off a new eye company called OpsiRx Pharmaceuticals, focused on the delivery of long-lasting products administered directly to the eye using minimally invasive needles. Release

> An intellectual property lawsuit related to the discovery of RNA interference brought against Carnegie Institution of Washington by a UMass researcher was thrown out of a U.S. District Court on a technicality. More (sub. req.)

> Liquidia Technologies formed a new oral health company, Lq3 Pharmaceuticals. The new Morrisville, NC-based company will use Liquidia's Particle Replication in Non-Wetting Templates nanoparticle development platform. Release

Suggested Articles

Genentech's Port Delivery System with ranibizumab matched Lucentis eye injections in a late-stage, wet age-related macular degeneration trial.

Honeywell aims to wean the industry of its glass habit with Aclar Edge, a new line of bottles and vials made with the company's patented plastic.

Astex's oral reformulation of a common chemo combo looks to replace lengthy infusions with a once-daily tablet that patients can take at home.